Newtyn Management »

Corcept Therapeutics Incorporated shares owned by Newtyn Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Newtyn Management from 13F filings

Historical chart of Newtyn Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Newtyn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Newtyn Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $7.0M 200k 34.80

More positions owned by Newtyn Management

United States Cellular Corporation (AD)
Indivior Ord
Quidel Corp (QDEL)
Harsco Corporation (NVRI)
Theravance Biopharma (TBPH)
Cannae Holdings (CNNE)
Apartment Invt & Mgmt Cl A (AIV)
Resolute Hldgs Mgmt (RHLD)
Integer Hldgs (ITGR)
Commscope Hldg
Magnera Corp Com Shs (MAGN)
Cogent Communications Hldgs Com New (CCOI)
Brightview Holdings (BV)
Iac Com New (IAC)
City Office Reit

View all positions for Newtyn Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Geode Capital Management
UBS Group
FMR
Dimensional Fund Advisors
AQR Capital Management
Caption Management
Charles Schwab Investment Management
TD Asset Management
Susquehanna International

View all funds holding Corcept Therapeutics Incorporated